Gene Silencing News and Research

RSS
Altered metabolism of two essential amino acids helps drive development of glioblastoma

Altered metabolism of two essential amino acids helps drive development of glioblastoma

Mtss1 'tumour suppressor' for CML

Mtss1 'tumour suppressor' for CML

ST Asia signs licensing deal with PharmaMar to distribute new multiple myeloma drug in South East Asia

ST Asia signs licensing deal with PharmaMar to distribute new multiple myeloma drug in South East Asia

Research sheds light on mechanism by which hemangioblasts become blood cells

Research sheds light on mechanism by which hemangioblasts become blood cells

New TAU study offers tangible hope of curing Mantle Cell Lymphoma

New TAU study offers tangible hope of curing Mantle Cell Lymphoma

Mutant protein responsible for cystic fibrosis talks to wrong cellular neighbors

Mutant protein responsible for cystic fibrosis talks to wrong cellular neighbors

Exploring how absence of ASS1 protein affects sick children may provide a 'lens' on cancer

Exploring how absence of ASS1 protein affects sick children may provide a 'lens' on cancer

Research reveals MECP2 Duplication Syndrome can be reversed

Research reveals MECP2 Duplication Syndrome can be reversed

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

First patients receive doses of antisense drug for Huntington's disease

First patients receive doses of antisense drug for Huntington's disease

Set of genes identified in human genome essential for survival, proliferation of human cell lines

Set of genes identified in human genome essential for survival, proliferation of human cell lines

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Researchers find way to trigger 'virus alert' that may help boost drug's ability to prevent cancer cells

Researchers find way to trigger 'virus alert' that may help boost drug's ability to prevent cancer cells

Regen BioPharma implements gene silencing technology in killing cancer stem cells

Regen BioPharma implements gene silencing technology in killing cancer stem cells

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Trends, R&D progress, and predicted revenues in RNAi therapies

Trends, R&D progress, and predicted revenues in RNAi therapies

Vital molecular mechanism in plants has similarities to certain signaling mechanisms in humans

Vital molecular mechanism in plants has similarities to certain signaling mechanisms in humans